[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369626-105":59,"doc-detail-369626-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","comprehensive-multi-omics-pan-cancer-analysis-revealed-egflam-as-a-potential-prognostic-and-immune-infiltration-associated-biomarker","Comprehensive multi-omics pan-cancer analysis revealed EGFLAM as a potential prognostic and immune infiltration-associated biomarker","","EGFLAM is a versatile protein expressed across human tissues, but its pan-cancer roles remain unclear. A comprehensive multi-omics pan-cancer analysis used public databases and bioinformatics tools, followed by in vitro confirmatory experiments in gastric cancer cell lines. EGFLAM was upregulated in multiple cancers, especially gastric cancer, and showed prognostic value. Dysregulation may involve promoter methylation changes, mRNA methylation, and genetic alterations, with links to immune infiltration, immune checkpoints, TMB, and MSI. Single-cell analysis indicated fibroblast-dominant expression, PI3K-AKT pathway and ECM receptor interactions, RT-qPCR validation, and knockdown suppressed proliferation, migration, invasion, and induced apoptosis, supporting prognostic and therapeutic targeting in gastric cancer.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/comprehensive-multi-omics-pan-cancer-analysis-revealed-egflam-as-a-potential-prognostic-and-immune-infiltration-associated-biomarker/369626/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/comprehensive-multi-omics-pan-cancer-analysis-revealed-egflam-as-a-potential-prognostic-and-immune-infiltration-associated-biomarker/369626.png","ImageObject",300,407,{"name":92,"@type":93},"Putri","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What approach was used to study EGFLAM across cancers?","Question",{"text":113,"@type":114},"The study performed comprehensive pan-cancer analysis using public databases and bioinformatics tools, followed by in vitro confirmatory experiments in gastric cancer cell lines.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does EGFLAM relate to patient outcomes?",{"text":118,"@type":114},"EGFLAM expression was elevated in multiple cancer types and showed prognostic predictive value, indicating potential as a prognostic biomarker.",{"name":120,"@type":111,"acceptedAnswer":121},"What mechanisms and biomarkers are associated with EGFLAM dysregulation?",{"text":122,"@type":114},"EGFLAM dysregulation was linked to promoter methylation changes, mRNA methylation modifications, and genetic alterations, and its expression correlated with immune infiltration, immune checkpoints, TMB, and MSI.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},369626,1790792907,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":26,"preview_page_count":19,"preview_urls":146},962085571259,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Yang et al. BMC Cancer (2025) 25:1109 BMC Cancer  \n[https://doi.org/10.1186/s12885-025-14519-9](https://doi.org/10.1186/s12885-025-14519-9)  \nRESEARCH Open Access  \nComprehensive multi-omics pan-cancer  analysis revealed EGFLAM as a potential prognostic and immune infiltration-associated biomarker  \nJian Yang 1,2,3,4†, Wenqian Xu 1,2,3,4†, Shengyu Wang 1,2,3,4, Zhu Yu2,3,4, Yue Feng 1,2,3,4, Da Li 1,2,3,4 and Junqiang Chen 1,2,3,4*  \nAbstract  \nEGFLAM is a versatile protein widely expressed in multiple human tissues, yet its function in pan-cancer is not fully understood. To investigate the molecular function of EGFLAM, a comprehensive pan-cancer analysis was carried out using several public databases and bioinformatics tools. Ultimately, confirmatory experiments were conducted in vitro with gastric cancer cell lines. The results showed that EGFLAM expression was elevated in multiple cancer types, especially gastric cancer. It also demonstrated prognostic predictive value in several cancer types, suggesting its potential as a prognostic biomarker. The dysregulation of EGFLAM expression observed in certain cancers might be attributed to factors such as promoter methylation changes, mRNA methylation modifications, and genetic alterations of the EGFLAM locus. EGFLAM expression was associated with Immune cell infiltration, immune checkpoints, tumor mutation burden (TMB), and microsatellite instability (MSI) . Single-cell analysis of gastric cancer showed that EGFLAM was predominantly expressed in fibroblast populations. Functional enrichment analyses (GO/ KEGG) demonstrated EGFLAM involvement in extracellular matrix receptor interactions and PI3K-AKT signaling pathway. RT‒qPCR confirmed EGFLAM upregulation in gastric cancer specimens compared to normal controls. In vitro functional assays revealed that EGFLAM knockdown significantly suppressed gastric cancer cell proliferation, migration, and invasion while inducing apoptosis. Collectively, our multi-omics analyses delineated EGFLAM's oncogenic functions across cancer types, positioning it as both a promising prognostic biomarker and a potential therapeutic target for gastric cancer.  \nKeywords EGFLAM, Pan-cancer, Prognosis, Immune infiltration, Gastric cancer, Biomarker  \n†JianYang and Wenqian Xu contributed equally to this work.  \n*Correspondence:  \nJunqiang Chen  \n[chenjunqiang@gxmu.edu.cn](chenjunqiang@gxmu.edu.cn)  \n1Department of Gastrointestinal Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China  \n2Guangxi Key Laboratory of Enhanced Recovery After Surgery for Gastrointestinal Cancer, Nanning, Guangxi Zhuang Autonomous Region, China  \n3Guangxi Clinical Research Center for Enhanced Recovery After Surgery, Nanning, Guangxi Zhuang Autonomous Region, China  \n4Guangxi Zhuang Autonomous Region Engineering Research Center for Artificial Intelligence Analysis of Multimodal Tumor Images, Nanning, Guangxi Zhuang Autonomous Region, China  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [htt","cbCaigcn1gyGpldB","https://ap.wps.com/l/cbCaigcn1gyGpldB","pdf",7177539,24,"English","# Abstract\n# Introduction","[{\"question\":\"What approach was used to study EGFLAM across cancers?\",\"answer\":\"The study performed comprehensive pan-cancer analysis using public databases and bioinformatics tools, followed by in vitro confirmatory experiments in gastric cancer cell lines.\"},{\"question\":\"How does EGFLAM relate to patient outcomes?\",\"answer\":\"EGFLAM expression was elevated in multiple cancer types and showed prognostic predictive value, indicating potential as a prognostic biomarker.\"},{\"question\":\"What mechanisms and biomarkers are associated with EGFLAM dysregulation?\",\"answer\":\"EGFLAM dysregulation was linked to promoter methylation changes, mRNA methylation modifications, and genetic alterations, and its expression correlated with immune infiltration, immune checkpoints, TMB, and MSI.\"}]","Comprehensive multi-omics pan-cancer analysis revealed EGFLAM as a potential prognostic and immune infiltration-associated biomarker | PDF",1790183740,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/38e57ed42a4201587a9cfdd43e31c40b.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2379ede6b29f7da98058f86841f8855f.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0b1e782ac70ef96100faaa9d86dd9c90.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b06c48c5cea658b988903ad55ea272ca.webp",980,1306]